Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DW4J
|
|||
| Former ID |
DNC000550
|
|||
| Drug Name |
Dibenzo-p-dioxin-2-carboxylic acid
|
|||
| Synonyms |
Oxanthrene-2-carboxylic acid; 17054-75-0; SCHEMBL18288092; ZINC34729704; AKOS000276725
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H8O4
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)OC3=C(O2)C=C(C=C3)C(=O)O
|
|||
| InChI |
1S/C13H8O4/c14-13(15)8-5-6-11-12(7-8)17-10-4-2-1-3-9(10)16-11/h1-7H,(H,14,15)
|
|||
| InChIKey |
MCNODAPWJQPAIE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DNA topoisomerase I (TOP1) | Target Info | Binder | [1] |
| NetPath Pathway | IL2 Signaling Pathway | |||
| Panther Pathway | DNA replication | |||
| Pathway Interaction Database | Caspase Cascade in Apoptosis | |||
| WikiPathways | Integrated Pancreatic Cancer Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Comparison of responses of DNA topoisomerase I from Candida albicans and human cells to four new agents which stimulate topoisomerase-dependent DNA nicking. FEMS Microbiol Lett. 1996 May 1;138(2-3):105-11. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.